ST. LOUIS--(BUSINESS WIRE)--CMS, Inc., the worldwide market leader in radiation treatment planning and workflow management, announced the signing of a collaboration agreement to provide treatment planning support for the new single-room proton beam radiotherapy system being developed by Still River Systems. The partnership leverages CMS’s existing clinical capabilities and market leadership position in proton treatment planning solutions with Still River Systems’ new proton delivery technology. Pursuant to the agreement, CMS and Still River Systems will work together to ensure that CMS’s XiO treatment planning system interfaces with and supports the specific planning requirements of Still River Systems’ Clinatron 250™ proton treatment system currently in development.
